Jonas S. Ogaard
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Intrahepatic T cell analysis reveals Th17 and MAIT17 enrichment in primary sclerosing cholangitis.
Journal: JHEP reports : innovation in hepatology
Published: August 21, 2025
Mucosal-Associated Invariant T Cells Drive Bile Duct Inflammation.
Journal: Cellular and molecular gastroenterology and hepatology
Published: April 11, 2025
Multimodal transcriptomics identifies metallothionein as a novel pathway in primary sclerosing cholangitis.
Journal: Hepatology (Baltimore, Md.)
Published: February 12, 2025
Natural Killer T cells promote cholestatic liver disease independent of antigen presentation by cholangiocytes.
Journal: Hepatology communications
Published: February 04, 2025
The N-6 methyladenosine dynamics in STEMI and the effect of IL-6 inhibition - a hypothesis generating sub-study of the ASSAIL-MI trial.
Journal: Frontiers in immunology
Published: November 21, 2024
Continuous infusion of resolvin D2 in combination with Angiotensin-II show contrary effects on blood pressure and intracardiac artery remodeling.
Journal: Biochemical and biophysical research communications
Published: July 30, 2024
Single-Cell Transcriptomic Profiling of Cholangiocyte Organoids Derived from Bile Ducts of Primary Sclerosing Cholangitis Patients.
Journal: Digestive diseases and sciences
Published: April 03, 2024
SLAMF1-derived peptide exhibits cardio protection after permanent left anterior descending artery ligation in mice.
Journal: Frontiers in immunology
Published: February 07, 2024
Microbial exposure during early life regulates development of bile duct inflammation.
Journal: Scandinavian journal of gastroenterology
Published: November 24, 2023
T cells with increased responsiveness cause obesity in mice without diet intervention.
Journal: iScience
Published: October 27, 2023
Last Updated: 09/26/2026